| DKT | dexketoprofen trometamol |
| DK | dexketoprofen |
| FaSSIF-v1 | fasted state simulated intestinal fluids version 1 |
| SGF | simulated gastric fluids |
| HPLC | high-performance liquid chromatography |
| LLPS | liquid–liquid phase separation |
| PK | pharmacokinetics |
| GIS | gastrointestinal simulator |
| USP | United States Pharmacopeia |
| GI | gastrointestinal |
| BE | bioequivalence |
| AUC | area under the curve |
| Cmax | maximal concentration |
| CH | high concentration of DKT |
| CL | low concentration of DKT |
| IVIVC | in vitro–in vivo correlation |
| REF | reference listed drug product |
| Non-BE | non-bioequivalent |
| Ssalt | Solubility of the salt form of dexketoprofen (i.e., dexketoprofen trometamol) |
| Sacid | Solubility of the salt form of dexketoprofen |
| NaCl | sodium chloride |
| S0 | intrinsic solubility of dexketoprofen |
| pHmax | the pHmax refers to the pH where both the DKT and free acid have equal solubilities. |
| Ksp | salt solubility product |
| TH+ | positively ionized trometamol |
| GISstomach | gastrointestinal simulator gastric chamber |
| GISduodenum | gastrointestinal simulator duodenal chamber |
| GISjejunum | gastrointestinal simulator jejunal chamber |
| Fa | fraction absorbed |
| HA | acid form |
| A− | negative ionized acid form |
| BH | protonated basic form |
| RE% | relative prediction error in percentage |
| EMA | European Medicines Agency |
| BCS | biopharmaceutics classification system |
| NaOH | sodium hydroxide |
| HCl | hydrochloric acid |
| TFA | trifluoracetic acid |